218 related articles for article (PubMed ID: 35398876)
1. COVID-19 vaccination-associated ipsilateral supraclavicular lymphadenopathy.
Jalani N; Tadj D
Aust J Gen Pract; 2021 Dec; 50():. PubMed ID: 35398876
[TBL] [Abstract][Full Text] [Related]
2. Supraclavicular lymphadenopathy following COVID-19 vaccination: an increasing presentation to the two-week wait neck lump clinic?
Mitchell OR; Dave R; Bekker J; Brennan PA
Br J Oral Maxillofac Surg; 2021 Apr; 59(3):384-385. PubMed ID: 33685772
[TBL] [Abstract][Full Text] [Related]
3. Acute onset supraclavicular lymphadenopathy coinciding with intramuscular mRNA vaccination against COVID-19 may be related to vaccine injection technique, Spain, January and February 2021.
Fernández-Prada M; Rivero-Calle I; Calvache-González A; Martinón-Torres F
Euro Surveill; 2021 Mar; 26(10):. PubMed ID: 33706861
[TBL] [Abstract][Full Text] [Related]
4. Supraclavicular lymphadenopathy after COVID-19 vaccination in Korea: serial follow-up using ultrasonography.
Kim B; Park Y; Kim EK; Lee SH
Clin Imaging; 2021 Nov; 79():201-203. PubMed ID: 34116295
[TBL] [Abstract][Full Text] [Related]
5. Supraclavicular lymphadenopathy after COVID-19 vaccination.
Larkin K; Sharma A; Drachtman R; Salaru G
Pediatr Blood Cancer; 2022 May; 69(5):e29516. PubMed ID: 34913588
[No Abstract] [Full Text] [Related]
6. FDG-Avid Ipsilateral Iliac and Inguinal Lymphadenopathy After COVID-19 Vaccination With Thigh Injection.
Bass D; Puri S
AJR Am J Roentgenol; 2022 Jan; 218(1):180. PubMed ID: 34259040
[No Abstract] [Full Text] [Related]
7. Supraclavicular lymphadenopathy secondary to COVID-19 BNT162b2 vaccine.
Roca B; Rambla M; Roca MM
J Postgrad Med; 2021; 67(3):180-181. PubMed ID: 34414929
[No Abstract] [Full Text] [Related]
8. Frequency and Characteristics of Nodal and Deltoid FDG and
Schroeder DG; Jang S; Johnson DR; Takahashi H; Navin PJ; Broski SM; Thorpe MP; Johnson GB; Young JR
AJR Am J Roentgenol; 2021 Nov; 217(5):1206-1216. PubMed ID: 34009000
[No Abstract] [Full Text] [Related]
9. COVID-19 Vaccination-Related Uptake on FDG PET/CT: An Emerging Dilemma and Suggestions for Management.
McIntosh LJ; Bankier AA; Vijayaraghavan GR; Licho R; Rosen MP
AJR Am J Roentgenol; 2021 Oct; 217(4):975-983. PubMed ID: 33646823
[TBL] [Abstract][Full Text] [Related]
10. Response to Letter; Discrimination between Benign and Malignant Post-SARS-CoV-2 Vaccination Lymphadenopathy is Feasible, to Our Article; Axillary Adenopathy in Patients with Recent COVID-19 Vaccination: A New Diagnostic Dilemma.
Ashoor A; Shephard J; Lissidini G; Nicosia L
Korean J Radiol; 2022 Jul; 23(7):775-776. PubMed ID: 35695318
[No Abstract] [Full Text] [Related]
11. Management Strategies for Patients Presenting With Symptomatic Lymphadenopathy and Breast Edema After Recent COVID-19 Vaccination.
Hao M; Edmonds CE; Nachiappan AC; Conant EF; Zuckerman SP
AJR Am J Roentgenol; 2022 Jun; 218(6):970-976. PubMed ID: 34964358
[TBL] [Abstract][Full Text] [Related]
12. Management of Unilateral Axillary Lymphadenopathy Detected on Breast MRI in the Era of COVID-19 Vaccination.
Edmonds CE; Zuckerman SP; Conant EF
AJR Am J Roentgenol; 2021 Oct; 217(4):831-834. PubMed ID: 33543649
[TBL] [Abstract][Full Text] [Related]
13. Frequency and Outcomes of Ipsilateral Axillary Lymphadenopathy After COVID-19 Vaccination.
Zhou W; DeMartini WB; Ikeda DM
JAMA Netw Open; 2022 Jun; 5(6):e2216172. PubMed ID: 35675077
[TBL] [Abstract][Full Text] [Related]
14. Lymphadenopathy in COVID-19 Vaccine Recipients: Diagnostic Dilemma in Oncologic Patients.
Özütemiz C; Krystosek LA; Church AL; Chauhan A; Ellermann JM; Domingo-Musibay E; Steinberger D
Radiology; 2021 Jul; 300(1):E296-E300. PubMed ID: 33625300
[TBL] [Abstract][Full Text] [Related]
15. Post-vaccination SARS-CoV-2 axillary adenopathy. Differences with axillary metastases from breast cancer.
Armas-Conde M; Sánchez-Álvarez ÁL; Tejera-Hernández A; Vega-Benítez V; Antela-López JC; Gutiérrez-Giner MI; Hernández-Hernández JR
Cir Cir; 2022; 90(3):410-413. PubMed ID: 35636962
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 Vaccination and Subclinical Axillary Lymphadenopathy on Mammogram: Correspondence.
Mungmunpuntipantip R; Wiwanitkit V
Acad Radiol; 2022 Apr; 29(4):633. PubMed ID: 35058134
[No Abstract] [Full Text] [Related]
17. COVID-19 vaccination and low cervical lymphadenopathy in the two week neck lump clinic - a follow up audit.
Mitchell OR; Couzins M; Dave R; Bekker J; Brennan PA
Br J Oral Maxillofac Surg; 2021 Jul; 59(6):720-721. PubMed ID: 33947605
[TBL] [Abstract][Full Text] [Related]
18. Incidence of Axillary Adenopathy in Breast Imaging After COVID-19 Vaccination.
Robinson KA; Maimone S; Gococo-Benore DA; Li Z; Advani PP; Chumsri S
JAMA Oncol; 2021 Sep; 7(9):1395-1397. PubMed ID: 34292295
[TBL] [Abstract][Full Text] [Related]
19. Discrimination between Benign and Malignant Post-SARS-CoV-2 Vaccination Lymphadenopathy is Feasible.
Finsterer J
Korean J Radiol; 2022 Jul; 23(7):773-774. PubMed ID: 35695321
[No Abstract] [Full Text] [Related]
20. Fine needle aspiration in COVID-19 vaccine-associated lymphadenopathy.
Hagen C; Nowack M; Messerli M; Saro F; Mangold F; Bode PK
Swiss Med Wkly; 2021 Jul; 151():w20557. PubMed ID: 34286849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
